Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.
Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trial
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Former White House ethics attorney: Taxpayer-funded ads could be ‘impeachable offense’
Former White House ethics attorney Richard Painter said the White House using taxpayer dollars for TV ads promoting Pres...
Hilton outlines English-only California schools plan
The Republican gubernatorial nominee in California says schools should go back to English-only classrooms. Steve Hilton...
Best thing we can offer young people is a job, not benefits, says chancellor
Image source, PA MediaImage caption, John Healey and cabinet ministers from the other great offices of state gave speech...
The legacy of Clarence Thomas will be declining trust in the Supreme Court
Supreme Court Justice Clarence Thomas faces a complicated historical legacy marked by record declines in public trust in...